Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program
Authors:
- Douglas J. BiedenbachDBDouglas J. Biedenbach
- David J. FarrellDFDavid J. Farrell
- Rodrigo E. MendesRMRodrigo E. Mendes
- James E. RossJRJames E. Ross
- Ronald N. JonesRJRonald N. Jones
- 1 December 2010
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 68 (4) , 459-467
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- First Report of Staphylococcal Clinical Isolates in Mexico with Linezolid Resistance Caused by cfr : Evidence of In Vivo cfr MobilizationJournal of Clinical Microbiology, 2010
- Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitalsJournal of Antimicrobial Chemotherapy, 2010
- Polyphyletic Emergence of Linezolid-Resistant Staphylococci in the United StatesAntimicrobial Agents and Chemotherapy, 2010
- First Report of cfr -Mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United StatesAntimicrobial Agents and Chemotherapy, 2008
- Zyvox® Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countriesDiagnostic Microbiology and Infectious Disease, 2007
- Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistantEnterococcus faeciumEpidemiology and Infection, 2007
- The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A AntibioticsAntimicrobial Agents and Chemotherapy, 2006
- Oxazolidinone susceptibility patterns in 2004: report from the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nationsJournal of Antimicrobial Chemotherapy, 2005
- Trends in linezolid susceptibility patterns in 2002: Report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum ProgramDiagnostic Microbiology and Infectious Disease, 2005
- Antimicrobial Resistance to LinezolidClinical Infectious Diseases, 2004